Wird geladen...
REGULATABLE PROMOTERS AND GENE THERAPY FOR PARKINSON'S DISEASE: IS THE ONLY THING TO FEAR, FEAR ITSELF?
Gene therapy for Parkinson's disease has become a clinical reality with three different approaches currently being tested in patients. All three trials employ an adeno-associated virus with a type two serotype (AAV2). To date, no serious adverse events related to the injections of therapeutic v...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2007
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3913266/ https://ncbi.nlm.nih.gov/pubmed/17888424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2007.08.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|